AP
ACADIA Pharmaceuticals Inc
🇩🇪XSTU.DR6GermanyHealthcare
€23.84EURup +0.72 (+3.11%)ClosedEnd of day9:47 PM
Price€23.84+0.72 (+3.11%)
Profile
- Healthcare
- Biotechnology
- Germany
Identity
- Exchange
- Stuttgart Stock Exchange . XSTU
- Type
- Stock
- ISIN
- US0042251084
- CUSIP
- Not reported
Company
- Employees
- 796
- Headquarters
- San Diego, United States
- Website
- https://www.acadia.com
- CEO
- Ms. Catherine E. Owen Adams
Market
- Shares outstanding
- 0
- Market cap
- Not reported
Highlights
- Market cap
- Not reported
- EPS LTM
- $2.20
- P/E LTM
- 11.57
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $1.14B+11.75%up year on year
- Net income
- $380.48M+71.27%up year on year
- Gross margin
- 91.13%-0.91%down year on year
- Free cash flow
- $174.39M-6.78%down year on year
Other listings
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.